At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 51 enrolled
Drug / intervention
Dexamethasone +1 moredrug
Likely dose
Dexamethasone 8mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Reconstructive Surgery: Is There A Role?
In Brief
A Phase 2 clinical trial evaluating Dexamethasone and Normal saline for Quality of Recovery and 3 related conditions. Completed, enrolled 51 participants across 1 site.
Detailed Summary
To the investigators knowledge there are no studies in the literature evaluating the effect of Dexamethasone administration on patients undergoing outpatient vaginal prolapse surgeries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsQuality of Recovery, Same Day Surgery, Nausea and Vomiting, Postoperative, Vaginal Prolapse
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
Enrollment StartMay 2017
First PostedNov 2017
Primary CompletionAug 2018
TodayJul 2026
First PostedNov 9, 2017
Enrollment StartMay 1, 2017
Primary CompletionAug 21, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.6 years ago
Interventions
Dexamethasonedrug
Patients will be randomized to Dexamethasone arm will receive 8mg (2ml) of Dexamethasone at the time of induction.
Normal salinedrug
Patients randomized to normal saline will receive 2ml of Normal saline at the time of induction.